Acurx Pharmaceuticals Inc expected to post a loss of 29 cents a share - Earnings Preview

Acurx Pharmaceuticals

10/05/2023 14:16

* Acurx Pharmaceuticals Inc  ACXP.OQ   ACXP.O  is expected
to show
no change in quarterly revenue when it reports  results on May
12. 
    * 
    * ​Refinitiv's mean analyst estimate for Acurx
Pharmaceuticals Inc
is for a loss of 29 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Acurx
Pharmaceuticals Inc is $14​, above​ its last closing price
of $3.25. ​​​

This summary was machine generated May 10 at 13:16 GMT.  All
figures in US dollars  unless otherwise stated